-

Pharmaceuticals and Biopharmaceuticals Lab Instrumentation Markets Report 2022: In-depth Examination of the Major Technologies Used in the Pharma/Bio Sector, Comprising 50 Technologies in 9 Categories - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Lab Instrumentation Markets for Pharmaceuticals and Biopharmaceuticals" report has been added to ResearchAndMarkets.com's offering.

Lab Instrumentation Markets for Pharmaceuticals and Biopharmaceuticals is an in-depth examination of the major technologies used in the pharma/bio sector, encompassing 50 technologies in 9 categories.

The report examines historical growth and provides forecasts for demand over the next five years. This report focuses on delivering insights into phases of discovery, therapeutic focus, and the challenges being faced in therapeutic development.

Drug development is a long and complicated process that involves several types of analytical instruments used in a variety of ways and purposes. Starting at early discovery, a targeted process occurs during drug and biomarker discovery to identify a drug candidate.

These drug candidates are then tested in preclinical and clinical trials, translational research, and finally manufacturing and QA/QC. Due to the nature of drugs and their interactions, knowing how a drug works, its side effects, the method of delivery, its efficacy, consistency in manufacturing, and more all must be tested using precise methods and accurate data.

The instruments covered in this report are the primary sources of that data and form the critical infrastructure for pharmaceutical and biotherapeutic compounds. Further, innovations in the instruments, software controlling them, and analysis methods will further drive new biotherapeutics and drug formulations that are key to the success of the industry.

At the heart of all drug development is the pharmaceutical, biotech, and biopharmaceutical companies. They account for the majority of demand for these instruments, as they are the main commercial benefactors of biotherapeutics.

These companies will often utilize contract research organizations and public sector organizations such as those in academia, the government, and research institutions to assist in the R&D process. Together and in conjunction with a regulatory framework, this network alongside instrument suppliers forms a fast growing marketplace that has only been further helped by steady government investment.

Future growth in the pharma/bio marketplace will be driven by new therapeutic modalities that are more specific to a certain disease, delivered in better ways, with faster research and production timelines, and an increased reliance on personalization to patients. The resulting price tag and need for specific capital and infrastructure will further rely on high throughput screening, automation, and reliance on CROs and CMOs that provide expertise and scale up resources.

Top Vendors include:

  • Bruker
  • Danaher
  • Illumina
  • MilliporeSigma
  • Perkin Elmer
  • QIAGEN
  • Sartorius
  • Tecan
  • Thermo Fisher
  • Waters

Key Topics Covered:

1. Introduction

  • About this Report
  • Scope and Methodology
  • Regional Segmentations
  • End Market & Sector Segmentations
  • Application Segmentations
  • Therapeutic Type Segmentation
  • Executive Summary

2. Background on the Pharma/Bio Sector

  • Introduction to the Pharma/Bio sector
  • Trends in Pharma/Bio
  • Market Opportunities
  • Market Threats

3. Laboratory Market Demand

  • Overall
  • Overall Demand by Technology, 2021-2026
  • Overall Demand by Sector, 2021-2026
  • Overall Demand by Lab Function, 2021-2026
  • Overall Demand by Region, 2021-2026
  • Overall Vendor Share, 2021
  • Overall Supplier Participation, 2021
  • Life Science Instrumentation
    • Life Science Instrumentation Demand by Technique, 2021-2026
    • Life Science Instrumentation Demand by Sector, 2021-2026
    • Life Science Instrumentation Demand by Lab Function, 2021-2026
    • Life Science Instrumentation Demand by Region, 2021-2026
    • Life Science Instrumentation Vendor Share, 2021
    • Life Science Instrumentation Supplier Participation, 2021
  • Molecular Biology
  • Chromatography
  • Bioprocessing
  • Imaging
  • Other Techniques

For more information about this report visit https://www.researchandmarkets.com/r/u9sxoy

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Personalized Ophthalmology Therapies Market Report 2025: $5.46 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Personalized Ophthalmology Therapies Market Report 2025" has been added to ResearchAndMarkets.com's offering. The personalized ophthalmology therapies market is experiencing significant growth, with an expected increase from $2.82 billion in 2024 to $3.23 billion in 2025, at a CAGR of 14.4%. This expansion is driven by the rising incidence of diabetes, aging populations, increased demand for precision medicine, and the growing prevalence of ophthalmic diseases. Loo...

Recruitment Advertising Agency Market Report 2025: $9.35 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Recruitment Advertising Agency Market Report 2025" has been added to ResearchAndMarkets.com's offering. The recruitment advertising agency market has experienced significant growth in recent years, expanding from $6.35 billion in 2024 to an anticipated $6.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.4%. This uptrend is largely driven by increased digital job postings, a rise in social media recruitment, and the growing demand for skilled...

Global Vinyl Acetate Monomer (VAM) Industry Outlook to 2030 - Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Vinyl Acetate Monomer (VAM) Industry Outlook to 2030 - Capacity and Capital Expenditure Forecasts with Details of All Active and Planned Plants" report has been added to ResearchAndMarkets.com's offering. Global Vinyl Acetate Monomer (VAM) capacity is poised to grow significantly by 30% during the 2025 to 2030 outlook period. VAM is a versatile chemical used to produce polymers and resins for a wide range of applications, most notably in adhesives, paints, a...
Back to Newsroom